Abstract | BACKGROUND: METHODS: We conducted a randomized, stratified, double-blind placebo-controlled trial to examine the incidence of PONV in women undergoing elective laparoscopic tubal ligation in the day surgery setting. DCL ( doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg) was administered orally the night before surgery, the morning of surgery, and upon hospital discharge. RESULTS: We enrolled 146 women in the trial, 127 of whom were included in the effectiveness analysis and 102 of whom were included in the efficacy analysis. We did not detect a difference in the incidence of nausea and vomiting in the first six hours postoperatively after adjusting for additional antiemetics administered. Patients receiving DCL as compared with placebo were significantly less likely to experience vomiting six to 24 hr postoperatively [5/59 (8.5%) vs 14/55 (25.4%), P < 0.017]. Treated patients tended to return to work earlier than those who received placebo (1.74 vs 3.7 days P = NS). CONCLUSION:
|
Authors | Brenda K Reeve, Deborah J Cook, Denise Babineau, L Cory Scholes, D Norman Buckley |
Journal | Canadian journal of anaesthesia = Journal canadien d'anesthesie
(Can J Anaesth)
Vol. 52
Issue 1
Pg. 55-61
(Jan 2005)
ISSN: 0832-610X [Print] United States |
PMID | 15625257
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antiemetics
- Drug Combinations
- dicyclomine, doxylamine, pyridoxine drug combination
- Dicyclomine
- Doxylamine
- Pyridoxine
|
Topics |
- Adult
- Ambulatory Surgical Procedures
- Antiemetics
(therapeutic use)
- Dicyclomine
- Double-Blind Method
- Doxylamine
(therapeutic use)
- Drug Combinations
- Female
- Humans
- Laparoscopy
- Postoperative Nausea and Vomiting
(epidemiology, prevention & control)
- Pyridoxine
(therapeutic use)
- Sample Size
- Sterilization, Tubal
- Treatment Outcome
|